REVIEW: Practical strategies to maintain anabolism by intravenous nutritional management in children with inborn metabolic diseases.

[1]  H. Yoshiji,et al.  Effect of L-carnitine on health-related quality of life in patients with liver cirrhosis , 2020, Biomedical reports.

[2]  J. Carpenter,et al.  Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing. , 2020, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[3]  T. Masaki,et al.  L-carnitine reduces hospital admissions in patients with hepatic encephalopathy. , 2020, European journal of gastroenterology & hepatology.

[4]  M. Kurosaki,et al.  Impaired brain function improved by l-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy , 2020, Scientific Reports.

[5]  J. Rho,et al.  Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms , 2020, Journal of inherited metabolic disease.

[6]  K. Lin,et al.  Application of ketogenic diets for pediatric neurocritical care , 2020, Biomedical journal.

[7]  F. K. Hendriks,et al.  End-Stage Renal Disease Patients Lose a Substantial Amount of Amino Acids during Hemodialysis , 2020, The Journal of nutrition.

[8]  V. Rubio,et al.  Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision , 2019, Journal of inherited metabolic disease.

[9]  R. Caraballo,et al.  Ketogenic parenteral nutrition in three paediatric patients with epilepsy with migrating focal seizures. , 2019, Epileptic disorders : international epilepsy journal with videotape.

[10]  J. Cross,et al.  Optimal clinical management of children receiving ketogenic parenteral nutrition: a clinical practice guide , 2019, Developmental medicine and child neurology.

[11]  Y. Takikawa,et al.  L‐carnitine prevents ammonia‐induced cytotoxicity and disturbances in intracellular amino acid levels in human astrocytes , 2018, Journal of gastroenterology and hepatology.

[12]  K. Nugent,et al.  Thiamine Deficiency: An Important Consideration in Critically Ill Patients. , 2018, The American journal of the medical sciences.

[13]  I. Scheffer,et al.  Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group , 2018, Epilepsia open.

[14]  S. Yamaguchi,et al.  Two siblings with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency suffered from rhabdomyolysis after l-carnitine supplementation , 2018, Molecular genetics and metabolism reports.

[15]  J. Guan,et al.  AMPK Inhibits ULK1-Dependent Autophagosome Formation and Lysosomal Acidification via Distinct Mechanisms , 2018, Molecular and Cellular Biology.

[16]  M. Summar,et al.  Inborn Errors of Metabolism with Hyperammonemia: Urea Cycle Defects and Related Disorders. , 2018, Pediatric clinics of North America.

[17]  D. Reijngoud.  Flux analysis of inborn errors of metabolism , 2018, Journal of Inherited Metabolic Disease.

[18]  A. Mühlebner,et al.  Ketogenic parenteral nutrition in 17 pediatric patients with epilepsy , 2017, Epilepsia open.

[19]  M. Birnbaum,et al.  Unraveling the Regulation of Hepatic Metabolism by Insulin , 2017, Trends in Endocrinology & Metabolism.

[20]  P. Taffé,et al.  Performance of Predictive Equations Specifically Developed to Estimate Resting Energy Expenditure in Ventilated Critically Ill Children , 2017, The Journal of pediatrics.

[21]  N. Darín,et al.  Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes , 2017, Journal of Inherited Metabolic Disease.

[22]  A. Lucia,et al.  Assessment of resting energy expenditure in pediatric mitochondrial diseases with indirect calorimetry. , 2016, Clinical nutrition.

[23]  N. Longo,et al.  Carnitine transport and fatty acid oxidation. , 2016, Biochimica et biophysica acta.

[24]  R. Mehta,et al.  Fluid overload in the ICU: evaluation and management , 2016, BMC Nephrology.

[25]  K. Tārs,et al.  Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria. , 2016, The Biochemical journal.

[26]  M. Puder,et al.  Intravenous Lipid Emulsions in Parenteral Nutrition. , 2015, Advances in nutrition.

[27]  D. Karall,et al.  Ketogenic diets in patients with inherited metabolic disorders , 2015, Journal of Inherited Metabolic Disease.

[28]  A. Gropman,et al.  Urea Cycle Disorders Overview , 2015 .

[29]  G. Van den Berghe,et al.  Metabolic and nutritional support of critically ill patients: consensus and controversies , 2015, Critical Care.

[30]  Marni J. Falk,et al.  Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society , 2014, Genetics in Medicine.

[31]  P. Marik,et al.  Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. , 2014, Anaesthesiology intensive therapy.

[32]  Anita MacDonald,et al.  Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia , 2014, Orphanet Journal of Rare Diseases.

[33]  G. Dore,et al.  Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders , 2014, Internal medicine journal.

[34]  A. Boneh.  Dietary protein in urea cycle defects: How much? Which? How? , 2014, Molecular genetics and metabolism.

[35]  H. Truby,et al.  New ways of defining protein and energy relationships in inborn errors of metabolism. , 2014, Molecular genetics and metabolism.

[36]  H. Sauerwein,et al.  Endogenous glucose production from infancy to adulthood: a non-linear regression model , 2014, Archives of Disease in Childhood.

[37]  A. Teleman,et al.  Regulation of TORC1 in Response to Amino Acid Starvation via Lysosomal Recruitment of TSC2 , 2014, Cell.

[38]  R. Grieve,et al.  A randomized trial of hyperglycemic control in pediatric intensive care. , 2014, The New England journal of medicine.

[39]  Marni J. Falk,et al.  Mitochondrial respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites. , 2013, Molecular genetics and metabolism.

[40]  Hoon-Chul Kang,et al.  Safety and role of ketogenic parenteral nutrition for intractable childhood epilepsy , 2012, Brain and Development.

[41]  Dieter Mesotten,et al.  Glycemic Targets and Approaches to Management of the Patient with Critical Illness , 2012, Current Diabetes Reports.

[42]  G. Hardy,et al.  Thiamine supplementation in the critically ill , 2011, Current opinion in clinical nutrition and metabolic care.

[43]  B. Zupec-Kania,et al.  Enteral and Parenteral Applications of Ketogenic Diet Therapy: Experiences From Four Centers , 2011 .

[44]  K. Ulate.  A critical appraisal of Vlasselaers D, Milants I, Desmet L, et al: Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study. Lancet 2009; 373:547–556 , 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[45]  N. Maraqa,et al.  Propionic acidemia mimicking diabetic ketoacidosis , 2011, Brain and Development.

[46]  M. Gillingham,et al.  Current issues regarding treatment of mitochondrial fatty acid oxidation disorders , 2010, Journal of Inherited Metabolic Disease.

[47]  E. Kraegen,et al.  Downregulation of AMPK Accompanies Leucine- and Glucose-Induced Increases in Protein Synthesis and Insulin Resistance in Rat Skeletal Muscle , 2010, Diabetes.

[48]  O. Tammela,et al.  Glucose infusions into peripheral veins in the management of neonatal hypoglycemia – 20% instead of 15%? , 2010, Acta paediatrica.

[49]  G. la Marca,et al.  Insulin-resistant hyperglycaemia complicating neonatal onset of methylmalonic and propionic acidaemias , 2009, Journal of Inherited Metabolic Disease.

[50]  M. Baumgartner,et al.  Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop , 2009, Journal of Inherited Metabolic Disease.

[51]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[52]  Rani H. Singh,et al.  Nutritional management of patients with urea cycle disorders , 2007, Journal of Inherited Metabolic Disease.

[53]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[54]  Brendan H. Lee,et al.  Nutritional management of urea cycle disorders. , 2005, Critical care clinics.

[55]  K. Simmer,et al.  Early introduction of lipids to parenterally-fed preterm infants. , 2005, The Cochrane database of systematic reviews.

[56]  Clare L Reid,et al.  Nutritional requirements of surgical and critically-ill patients: do we really know what they need? , 2004, The Proceedings of the Nutrition Society.

[57]  R. Dhanireddy,et al.  Aggressive Early Total Parental Nutrition in Low-Birth-Weight Infants , 2004, Journal of Perinatology.

[58]  Rani H. Singh,et al.  Management of fatty acid oxidation disorders: a survey of current treatment strategies. , 2002, Journal of the American Dietetic Association.

[59]  E. Puffenberger,et al.  Diagnosis and treatment of maple syrup disease: a study of 36 patients. , 2002, Pediatrics.

[60]  L. Saiman,et al.  Risk factors for candidemia in Neonatal Intensive Care Unit patients , 2000, The Pediatric infectious disease journal.

[61]  N. Maxvold,et al.  Amino acid loss and nitrogen balance in critically ill children with acute renal failure: A prospective comparison between classic hemofiltration and hemofiltration with dialysis , 2000, Critical care medicine.

[62]  M. Durán,et al.  The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency , 1998, Journal of Inherited Metabolic Disease.

[63]  O. Linderkamp,et al.  Assessment of energy expenditure in metabolic disorders , 1997, European Journal of Pediatrics.

[64]  P. Chessex,et al.  Glutathione deficiency as a complication of methylmalonic acidemia: response to high doses of ascorbate. , 1996, The Journal of pediatrics.

[65]  T A Ikizler,et al.  Amino acid and albumin losses during hemodialysis. , 1994, Kidney international.

[66]  S. Rahman,et al.  Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency , 1994, Journal of Inherited Metabolic Disease.

[67]  A. Pierro,et al.  Glucose utilization in the surgical newborn infant receiving total parenteral nutrition. , 1993, Journal of pediatric surgery.

[68]  R. Butterworth,et al.  Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy. , 1993, Metabolism: clinical and experimental.

[69]  D. Francis,et al.  Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management. , 1991, The Journal of pediatrics.

[70]  A. Munnich,et al.  The fasting test in paediatrics: Application to the diagnosis of pathological hypo- and hyperketotic states , 1990, European Journal of Pediatrics.

[71]  P. Krause,et al.  Effects of intravenous fat infusion on neonatal neutrophil and platelet function. , 1989, JPEN. Journal of parenteral and enteral nutrition.

[72]  S. Cederbaum,et al.  Parenteral nutrition in propionic and methylmalonic acidemia. , 1989, The Journal of pediatrics.

[73]  G. Putet,et al.  Energy Substrate Utilization in Infants Receiving Total Parenteral Nutrition with Different Glucose to Fat Ratios , 1989, Pediatric Research.

[74]  Robert A. Smith,et al.  Hemodynamic and gas exchange alterations during Intralipid infusion in patients with adult respiratory distress syndrome. , 1989, Chest.

[75]  R. Deckelbaum,et al.  Intralipid infusion into humans reduces in vitro platelet aggregation and alters platelet lipid composition. , 1989, Metabolism: clinical and experimental.

[76]  J. Bass,et al.  Intralipid causing adult respiratory distress syndrome. , 1984, Journal of the National Medical Association.

[77]  R. Boeckx,et al.  Methylmalonic acidemia with the unusual complication of severe hyperglycemia. , 1982, Clinical chemistry.

[78]  R. Redline,et al.  Malassezia pulmonary vasculitis in an infant on long-term Intralipid therapy. , 1981, The New England journal of medicine.

[79]  P. Garlick,et al.  Diurnal pattern of protein and energy metabolism in man , 1980 .

[80]  J. Kinney,et al.  Nonsuppressability of gluconeogenesis by glucose in septic patients. , 1976, Metabolism: clinical and experimental.

[81]  G. Lynch,et al.  Maple Syrup Urine Disease , 1964, Journal of mental deficiency research.

[82]  I. Vanhorebeek,et al.  Glucose homeostasis, nutrition and infections during critical illness. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[83]  S. Irving,et al.  Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. , 2017, JPEN. Journal of parenteral and enteral nutrition.

[84]  V. Sutton,et al.  Acute management of propionic acidemia. , 2012, Molecular genetics and metabolism.

[85]  T. Derks,et al.  Safe and unsafe duration of fasting for children with MCAD deficiency , 2006, European Journal of Pediatrics.

[86]  M. Rennie,et al.  Branched-chain amino acids as fuels and anabolic signals in human muscle. , 2006, The Journal of nutrition.

[87]  L. Kozák,et al.  Serum free carnitine in medium chain acyl-CoA dehydrogenase deficiency. , 2003, Bratislavske lekarske listy.

[88]  P. Thureen,et al.  Effect of Low versus High Intravenous Amino Acid Intake on Very Low Birth Weight Infants in the Early Neonatal Period , 2003, Pediatric Research.

[89]  M. Tuchman,et al.  Proceedings of a consensus conference for the management of patients with urea cycle disorders. , 2001, The Journal of pediatrics.

[90]  D. Millington,et al.  Carnitine homeostasis in the organic acidurias. , 1990, Progress in clinical and biological research.